Thermo Fisher Scientific has opened an $18 million, 8,000-square-meter distribution and labeling center in Uppsala, Sweden, to support global supply of immunodiagnostics for allergy and autoimmune disease testing.
The Galleri blood test demonstrated a four-fold increase in cancer detection rates and substantial reduction in stage IV cancer diagnoses in 142,000 participants.
Labcorp is expanding its partnership with PathAI to deploy the FDA-cleared AISight Dx digital pathology platform across its national network, enabling fully digital workflows and AI-supported diagnostics in anatomic pathology labs.
The Association for Diagnostics & Laboratory Medicine is urging Congress and federal agencies to update regulations to address AI bias in clinical lab systems, citing risks to marginalized patient groups from models trained on limited data.
A multicenter study reports that combining fecal SDC2 methylation testing with the APCS scoring system improves advanced adenoma detection and specificity in colorectal cancer screening.
